ALT vs V · rev $20.0K vs P/E 33, rev $40.00B
Altimmune Inc (ALT) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
ALT currently screens at market cap $527.0M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the ALT and V stock pages for the full models.
Not investment advice.